Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
2010 · New England Journal of Medicine · 5,521 citations
https://doi.org/10.1056/nejmoa0909530
K
Kunihiko Kobayashi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
859
Papers
23.8K
Citations
67
h-index
326
i10-index
Kunihiko Kobayashi is an academic researcher from Saitama Prefecture. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 67, co-authored 731 publications.
ORCID: 0000-0002-6468-9068Papers by this author
worksOsimertinib with or without Chemotherapy in <i>EGFR</i> -Mutated Advanced NSCLC
2023 · New England Journal of Medicine · 546 citations
https://doi.org/10.1056/nejmoa2306434
Gefitinib for non-small-cell lung cancer patients with epidermal growth factor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp
2006 · British Journal of Cancer · 167 citations
https://doi.org/10.1038/sj.bjc.6603466
Osimertinib plus platinum–pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results from the FLAURA2 study
2021 · ESMO Open · 63 citations
https://doi.org/10.1016/j.esmoop.2021.100271
Quantitative and compositional changes in high density lipoprotein subclasses in patients with various genotypes of cholesteryl ester transfer protein deficiency
1997 · Journal of Lipid Research · 47 citations
https://doi.org/10.1016/s0022-2275(20)37202-3
Cross-cultural comparison of breast cancer patients’ Quality of Life in the Netherlands and Japan
2017 · Breast Cancer Research and Treatment · 33 citations
https://doi.org/10.1007/s10549-017-4417-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat